Thompson Davis & Co., Inc. Prime Medicine, Inc. Transaction History

Thompson Davis & Co., Inc.

  • $159 Million
  • Q4 2025

A detailed history of Thompson Davis & Co., Inc. transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Thompson Davis & Co., Inc. holds 22,740 shares of PRME stock, worth $76,633. This represents 0.05% of its overall portfolio holdings.

Number of Shares
22,740
Previous 27,573 17.53%
Holding current value
$76,633
Previous $152,000 50.0%
% of portfolio
0.05%
Previous 0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 12, 2026
SELL
$3.33 - $6.67 $16,093 - $32,236
-4,833 Reduced 17.53%
22,740 $76,000
Q3 2025

Nov 05, 2025
BUY
$2.73 - $5.56 $75,274 - $153,305
27,573 New
27,573 $152,000

Others Institutions Holding PRME

# of Institutions
180
Shares Held
89M
Call Options Held
1.32M
Put Options Held
931K
View Full List

About Prime Medicine, Inc.

PRME Quotes by TradingView
  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $323M
More about PRME
Track This Portfolio

Track Thompson Davis & Co., Inc. Portfolio

Follow Thompson Davis & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thompson Davis & Co., Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email